Stephen C. Mathai

11.6k total citations · 2 hit papers
189 papers, 7.0k citations indexed

About

Stephen C. Mathai is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen C. Mathai has authored 189 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 175 papers in Pulmonary and Respiratory Medicine, 81 papers in Cardiology and Cardiovascular Medicine and 44 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen C. Mathai's work include Pulmonary Hypertension Research and Treatments (158 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers) and Systemic Sclerosis and Related Diseases (44 papers). Stephen C. Mathai is often cited by papers focused on Pulmonary Hypertension Research and Treatments (158 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (48 papers) and Systemic Sclerosis and Related Diseases (44 papers). Stephen C. Mathai collaborates with scholars based in United States, Italy and France. Stephen C. Mathai's co-authors include Paul M. Hassoun, Reda E. Girgis, Hunter C. Champion, Laura K. Hummers, Traci Housten-Harris, Micah R. Fisher, Sonye K. Danoff, Ari Zaiman, Fredrick M. Wigley and Ryan J. Tedford and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Stephen C. Mathai

178 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension

2006 787 citations Micah R. Fisher, Stephen C. Mathai et al. American Journal of Respiratory and Critical Care Medicine profile →
Treatment algorithm for pulmonary arterial hypertension

2024 50 citations Stephen C. Mathai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen C. Mathai United States	43	5.9k	3.6k	1.6k	906	762	189	7.0k
Gerry Coghlan United Kingdom	41	5.2k 0.9×	2.8k 0.8×	2.5k 1.6×	769 0.8×	942 1.2×	145	7.3k
Reda E. Girgis United States	45	5.9k 1.0×	3.4k 1.0×	1.1k 0.7×	1.1k 1.2×	1.8k 2.4×	136	7.7k
Robin Condliffe United Kingdom	41	5.5k 0.9×	3.5k 1.0×	557 0.4×	696 0.8×	565 0.7×	161	6.6k
Christopher P. Denton United Kingdom	13	4.0k 0.7×	2.1k 0.6×	834 0.5×	601 0.7×	572 0.8×	24	4.7k
Paul R. Forfia United States	34	4.1k 0.7×	4.1k 1.1×	376 0.2×	1.1k 1.2×	851 1.1×	114	5.9k
Jean‐Luc Vachiéry Belgium	32	4.9k 0.8×	3.7k 1.0×	281 0.2×	637 0.7×	1.2k 1.5×	132	6.1k
Carmine Dario Vizza Italy	34	3.8k 0.6×	3.2k 0.9×	299 0.2×	578 0.6×	686 0.9×	214	4.9k
Chris Denton United Kingdom	19	3.0k 0.5×	1.5k 0.4×	1.1k 0.7×	502 0.6×	519 0.7×	38	3.9k
Myung H. Park United States	22	3.1k 0.5×	2.9k 0.8×	198 0.1×	486 0.5×	987 1.3×	64	4.5k
Michele D’Alto Italy	33	2.7k 0.5×	2.5k 0.7×	256 0.2×	882 1.0×	493 0.6×	152	3.6k

Countries citing papers authored by Stephen C. Mathai

Since Specialization

Citations

This map shows the geographic impact of Stephen C. Mathai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Mathai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Mathai more than expected).

Fields of papers citing papers by Stephen C. Mathai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Mathai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Mathai. The network helps show where Stephen C. Mathai may publish in the future.

Co-authorship network of co-authors of Stephen C. Mathai

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Mathai. A scholar is included among the top collaborators of Stephen C. Mathai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Mathai. Stephen C. Mathai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balasubramanian, Aparna, Jude Moutchia, Kayleen Williams, et al.. (2025). Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry. Annals of the American Thoracic Society. 22(9). 1351–1360.

Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2025). Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension. Circulation Heart Failure. 18(8). e012912–e012912. 1 indexed citations

Mathai, Stephen C.. (2024). Pulmonary Hypertension Associated with Connective Tissue Disease. Rheumatic Disease Clinics of North America. 50(3). 359–379. 2 indexed citations

Reddy, Yogesh N.V., Robert P. Frantz, Paul M. Hassoun, et al.. (2024). Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. Journal of the American College of Cardiology. 84(22). 2196–2210. 6 indexed citations

Reddy, Yogesh N.V., Hilary M. DuBrock, Paul M. Hassoun, et al.. (2024). Non-Invasive Prediction of Pulmonary Vascular Disease-Related Exercise Intolerance and Survival in Non-Group 1 Pulmonary Hypertension. European Journal of Heart Failure. 26(11). 2323–2336. 1 indexed citations

Kawut, Steven M., Rui Feng, Susan S. Ellenberg, et al.. (2024). Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 210(9). 1143–1151. 14 indexed citations

Simpson, Catherine E., Julie Coursen, Steven Hsu, et al.. (2023). Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(6). L836–L848. 14 indexed citations

Naranjo, Mario, Erika B. Rosenzweig, Anna R. Hemnes, et al.. (2023). Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary Circulation. 13(3). e12281–e12281. 5 indexed citations

Pavlovic, Noelle, Jan M. Griffin, David R. Okada, et al.. (2022). Cardiac sarcoidosis outcome differences: A comparison of patients with de novo cardiac versus known extracardiac sarcoidosis at presentation. Respiratory Medicine. 198. 106864–106864. 17 indexed citations

10.

Sahay, Sandeep, Oksana A. Shlobin, Francisco Rafael Martins Soto, et al.. (2022). Effects of COVID-19 pandemic on the management of pulmonary hypertension. Respiratory Medicine. 206. 107061–107061. 3 indexed citations

11.

Johnson, Shelsey W., et al.. (2022). Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing. Pulmonary Circulation. 12(3). e12126–e12126. 5 indexed citations

12.

Mathai, Stephen C.. (2021). Pulmonary Hypertension Associated with Connective Tissue Disease. Cardiology Clinics. 40(1). 29–43. 8 indexed citations

13.

Seth, Bhavna, Judith B. Vick, Hannah J. Brown, et al.. (2021). A scoping review of palliative care outcome measures in interstitial lung disease. European Respiratory Review. 30(161). 210080–210080. 4 indexed citations

14.

Crnković, Slaven, Bakytbek Egemnazarov, Rachel L. Damico, et al.. (2018). Disconnect between Fibrotic Response and Right Ventricular Dysfunction. American Journal of Respiratory and Critical Care Medicine. 199(12). 1550–1560. 31 indexed citations

15.

Kelemen, Benjamin W., Stephen C. Mathai, Rachel L. Damico, et al.. (2017). Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulmonary Circulation. 7(2). 409–420. 35 indexed citations

16.

Tedford, Ryan J., Benjamin W. Kelemen, Stephen C. Mathai, et al.. (2014). Abstract 11450: Comparison of Simplified (Single-beat) Estimates to Measured Right Ventricular End-Systolic Elastance and RV-Pulmonary Vascular Coupling in Patients With Pulmonary Hypertension. Circulation. 1 indexed citations

17.

Tedford, Ryan J., James O. Mudd, Reda E. Girgis, et al.. (2013). Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension. Circulation Heart Failure. 6(5). 953–963. 182 indexed citations

18.

Tedford, Ryan J., Claude A. Beaty, Stephen C. Mathai, et al.. (2013). Abstract 15865: Diastolic Pulmonary Artery Pressure to Pulmonary Capillary Wedge Pressure Gradient (DPG) in Over 5700 Patients With an Elevated Transpulmonary Gradient Does Not Predict Survival After Cardiac Transplantation. Circulation. 128. 1 indexed citations

19.

Yarmus, Lonny, Jason Akulian, Christopher R. Gilbert, et al.. (2013). Comparison of Moderate versus Deep Sedation for Endobronchial Ultrasound Transbronchial Needle Aspiration. Annals of the American Thoracic Society. 10(2). 121–126. 78 indexed citations

20.

Mathai, Stephen C., Micah R. Fisher, Traci Housten-Harris, Reda E. Girgis, & Paul M. Hassoun. (2005). THE ADDITION OF SILDENAFIL TO BOSENTAN THERAPY IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION. CHEST Journal. 128(4). 161S–161S. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact